Literature DB >> 6099095

Antibody engineering, a strategy for the development of monoclonal antibodies.

O T Schönherr, E H Houwink.   

Abstract

Antibody engineering is the selection process enabling the isolation of hybridoma clones, each of which produces an antibody with predefined qualities. The state of the art of hybridoma technology is reviewed with emphasis on the results obtained by antibody engineering in our laboratories for the development of monoclonal antibodies for specific use in diagnostic tests. The perspective for in vitro monoclonal antibody production as well as the application of monoclonal antibodies for diagnostic reagents, industrial purification and therapeutic use are indicated.

Mesh:

Substances:

Year:  1984        PMID: 6099095     DOI: 10.1007/bf02386229

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  42 in total

1.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  The production of monoclonal antibodies from human lymphocytes.

Authors:  D Kozbor; J C Roder
Journal:  Immunol Today       Date:  1983-03

3.  Antibodies that react with predetermined sites on proteins.

Authors:  J G Sutcliffe; T M Shinnick; N Green; R A Lerner
Journal:  Science       Date:  1983-02-11       Impact factor: 47.728

4.  Tapping the immunological repertoire to produce antibodies of predetermined specificity.

Authors:  R A Lerner
Journal:  Nature       Date:  1982-10-14       Impact factor: 49.962

5.  Automated production of monoclonal antibodies in a cytostat.

Authors:  S Fazekas de St Groth
Journal:  J Immunol Methods       Date:  1983-02-25       Impact factor: 2.303

6.  Antigen-specific identification and cloning of hybridomas with a fluorescence-activated cell sorter.

Authors:  D R Parks; V M Bryan; V T Oi; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

7.  Development, screening and quality specifications of hybridomas synthesizing anti-polypeptide hormone antibodies to be used for diagnostic tests and in-process control.

Authors:  O T Schönherr; H W Roelofs; E H Houwink
Journal:  Dev Biol Stand       Date:  1983

8.  Production of human hybridomas secreting antibodies to measles virus.

Authors:  C M Croce; A Linnenbach; W Hall; Z Steplewski; H Koprowski
Journal:  Nature       Date:  1980-12-04       Impact factor: 49.962

9.  Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity.

Authors:  L Olsson; H S Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

10.  Myocardial infarct imaging of antibodies to canine cardiac myosin with indium-111-diethylenetriamine pentaacetic acid.

Authors:  B A Khaw; F T Fallon; H W Strauss; E Haber
Journal:  Science       Date:  1980-07-11       Impact factor: 47.728

View more
  3 in total

1.  Monoclonal antibodies and immobilized antibodies. Patents and literature.

Authors:  R J Linhardt
Journal:  Appl Biochem Biotechnol       Date:  1987-06       Impact factor: 2.926

2.  Monoclonal Antibodies to Plant Growth Regulators: III. Zeatinriboside and Dihydrozeatinriboside.

Authors:  J Eberle; A Arnscheidt; D Klix; E W Weiler
Journal:  Plant Physiol       Date:  1986-06       Impact factor: 8.340

Review 3.  Hybridoma technology: new developments of practical interest.

Authors:  S R Samoilovich; C B Dugan; A J Macario
Journal:  J Immunol Methods       Date:  1987-08-03       Impact factor: 2.303

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.